NO20031838L - Benzoksazinonderivater, deres fremstilling av anvendelse - Google Patents

Benzoksazinonderivater, deres fremstilling av anvendelse

Info

Publication number
NO20031838L
NO20031838L NO20031838A NO20031838A NO20031838L NO 20031838 L NO20031838 L NO 20031838L NO 20031838 A NO20031838 A NO 20031838A NO 20031838 A NO20031838 A NO 20031838A NO 20031838 L NO20031838 L NO 20031838L
Authority
NO
Norway
Prior art keywords
preparation
benzoxazinone derivatives
benzoxazinone
derivatives
Prior art date
Application number
NO20031838A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031838D0 (no
Inventor
Christopher Norbert Johnson
Harshad Kantilal Rami
Geoffrey Stemp
Kevin Michael Thewlis
Mervyn Thompson
Antonio Kuok Keong Vong
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0026224A external-priority patent/GB0026224D0/en
Priority claimed from GB0111858A external-priority patent/GB0111858D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20031838D0 publication Critical patent/NO20031838D0/no
Publication of NO20031838L publication Critical patent/NO20031838L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20031838A 2000-10-26 2003-04-24 Benzoksazinonderivater, deres fremstilling av anvendelse NO20031838L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0026224A GB0026224D0 (en) 2000-10-26 2000-10-26 Novel compounds
GB0111858A GB0111858D0 (en) 2001-05-15 2001-05-15 Novel compounds
PCT/EP2001/012344 WO2002034754A2 (en) 2000-10-26 2001-10-22 Benzoxazinone derivatives, their preparation and use

Publications (2)

Publication Number Publication Date
NO20031838D0 NO20031838D0 (no) 2003-04-24
NO20031838L true NO20031838L (no) 2003-06-24

Family

ID=26245199

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031838A NO20031838L (no) 2000-10-26 2003-04-24 Benzoksazinonderivater, deres fremstilling av anvendelse

Country Status (20)

Country Link
US (1) US6939871B2 (pt)
EP (1) EP1330460B1 (pt)
JP (1) JP4242643B2 (pt)
KR (1) KR20030051747A (pt)
CN (1) CN1478092A (pt)
AR (1) AR034174A1 (pt)
AT (1) ATE357448T1 (pt)
AU (1) AU2002224791A1 (pt)
BR (1) BR0114881A (pt)
CA (1) CA2426706A1 (pt)
CZ (1) CZ20031163A3 (pt)
DE (1) DE60127434T2 (pt)
ES (1) ES2280417T3 (pt)
HU (1) HUP0301458A2 (pt)
IL (1) IL155520A0 (pt)
MX (1) MXPA03003820A (pt)
NO (1) NO20031838L (pt)
PL (1) PL366378A1 (pt)
TW (1) TWI237023B (pt)
WO (1) WO2002034754A2 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203811D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0203804D0 (en) 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0203778D0 (en) * 2002-02-18 2002-04-03 Glaxo Group Ltd Compounds
GB0209244D0 (en) * 2002-04-23 2002-06-05 Glaxo Group Ltd Compounds
WO2004029048A1 (en) * 2002-09-26 2004-04-08 Warner-Lambert Company Llc Heterocyclic substituted piperazines for the treatment of schizophrenia
DE50312598D1 (de) 2002-10-10 2010-05-20 Morphochem Ag Komb Chemie Neue verbindungen mit antibakterieller aktivität
DE60318733T2 (de) 2002-11-08 2009-01-15 F. Hoffmann-La Roche Ag Substituierte benzoxazinones und ihre verwendung
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds
UA82875C2 (en) * 2003-04-30 2008-05-26 Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives and method for controlling insects
GB0310849D0 (en) * 2003-05-12 2003-06-18 Glaxo Group Ltd Compounds
GB0310851D0 (en) * 2003-05-12 2003-06-18 Glaxo Group Ltd Compounds
GB0316915D0 (en) 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
CN101365696A (zh) * 2004-07-28 2009-02-11 Irm责任有限公司 作为类固醇激素核受体调节剂的化合物和组合物
KR20080064953A (ko) * 2005-10-13 2008-07-10 모르포켐 악티엥게셀샤프트 퓌르 콤비나토리셰 케미 항균 활성을 갖는 5-퀴놀린 유도체
JP5662346B2 (ja) 2009-01-21 2015-01-28 バジリア ファルマスーチカ アーゲーBasilea Pharmaceutica AG 新規二環式抗生物質
KR101891834B1 (ko) 2009-12-18 2018-09-28 바실리어 파마슈티카 아게 트리시클릭 항생제
US9321788B2 (en) 2011-06-17 2016-04-26 Basilea Pharmaceutica Ag Tricyclic antibiotics
MX2018014032A (es) 2017-03-20 2019-08-21 Forma Therapeutics Inc Composiciones de pirrolopirrol como activadores de piruvato cinasa (pkr).
EP3853206B1 (en) 2018-09-19 2024-04-10 Novo Nordisk Health Care AG Treating sickle cell disease with a pyruvate kinase r activating compound
CN113226356A (zh) 2018-09-19 2021-08-06 福马治疗股份有限公司 活化丙酮酸激酶r

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997045419A1 (en) 1996-05-29 1997-12-04 Warner-Lambert Company Benzoxazinone dopamine d4 receptor antagonists
EP0900792B1 (en) * 1997-09-02 2003-10-29 Duphar International Research B.V Piperazine and piperidine derivatives as 5-HT1A and dopamine D2-receptor (ant)agonists
TW546299B (en) 1999-01-07 2003-08-11 Wyeth Corp 3,4-dihydro-2H-benzo[1,4]oxazinyl-methyl-[3-(1H-indol-3-yl)-alkyl]-amines
AU2494300A (en) 1999-01-07 2000-07-24 American Home Products Corporation 3,4-dihydro-2h-benzo(1,4)oxazine derivatives

Also Published As

Publication number Publication date
MXPA03003820A (es) 2003-07-28
AU2002224791A1 (en) 2002-05-06
DE60127434T2 (de) 2007-11-29
CZ20031163A3 (cs) 2004-04-14
PL366378A1 (en) 2005-01-24
AR034174A1 (es) 2004-02-04
CN1478092A (zh) 2004-02-25
EP1330460B1 (en) 2007-03-21
EP1330460A2 (en) 2003-07-30
IL155520A0 (en) 2003-11-23
JP4242643B2 (ja) 2009-03-25
US20040063704A1 (en) 2004-04-01
ES2280417T3 (es) 2007-09-16
NO20031838D0 (no) 2003-04-24
WO2002034754A2 (en) 2002-05-02
KR20030051747A (ko) 2003-06-25
ATE357448T1 (de) 2007-04-15
WO2002034754A3 (en) 2002-07-11
US6939871B2 (en) 2005-09-06
TWI237023B (en) 2005-08-01
DE60127434D1 (de) 2007-05-03
HUP0301458A2 (hu) 2003-10-28
JP2004516250A (ja) 2004-06-03
BR0114881A (pt) 2003-09-30
CA2426706A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
NO20031838L (no) Benzoksazinonderivater, deres fremstilling av anvendelse
NO20030134L (no) Fremstilling av olefinderivater
NO20024742D0 (no) Heterocykliske forbindelser, deres fremstilling og anvendelse
AR028567A1 (es) Nuevos derivados de fenil-propargileter
NO20013945D0 (no) Fremstilling av isoflavonderivater
AR028596A1 (es) Nuevos derivados de fenilglicina
NO20024175L (no) Azetidinderivater, deres fremstilling og farmasöytiske preparater inneholdende forbindelsene
EE201300011A (et) Ksantiini derivaadid, nende valmistamine ja kasutamine ravimina
ID30590A (id) Celana sekali pakai jenis-celana pendek
NO20024176L (no) Farmasöytiske preparater inneholder derivater av 3-amino- azetidin, de nye derivater og deres fremstilling
EE200200573A (et) Indoliin-2-ooni derivaadid, nende valmistamine jakasutamine oksütotsiiniretseptorite ligandidena
NO20032234D0 (no) Nye imidazolderivater, deres fremstilling og anvendelse
NO20032731D0 (no) Fremgangsmåte for fremstilling av sulfonamid-substituerte imidazotriazinoner
ATE414056T1 (de) Substituierte c-cyclohexylmethylamin-derivative
DE60142051D1 (de) Herstellung von perfluorolefinen
DE60144456D1 (de) DibenzoÄb,fÜazepin-Derivate und ihre Herstellung
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
NO20025423D0 (no) FremgangsmÕte for fremstilling av Citalopram
ATE282021T1 (de) Substituierte aminomethyl-phenyl- cyclohexanderivate
NO20024707L (no) Fremstilling av diacetaler av glyoksal
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
DK1322590T3 (da) Substituerede 5-amino-1-penten-3-ol-derivater
FI20002526A (fi) Pyridatsinonijohdannaisten uusi käyttö
DK1246793T3 (da) Substituerede aminomethyl-phenyl-cyclohexanderivater